To better understand the prognostic effect of multiple genetic markers and identify more subpopulations at ultra high risk of poor outcome, this study determined the status of the MYCN gene, 1p36 and 11q23 simultaneously in a large series of BM metastatic NB, compared their clinical features and analysed the survival situations separately and together. This evidence concerns the gene MYCN and neuroblastoma.